Objective The Patient Acceptable Symptomatic State (PASS) is the highest level of
symptoms beyond which patients consider themselves well. It provides clinically meaningful …

Objectives: Everolimus, a proliferation signal inhibitor with disease-modifying properties,
may be useful in treating rheumatoid arthritis (RA). This proof-of-concept study assessed …

Objective To assess the 2-year effect on disease activity and health-related quality of life (HRQoL)
of implementing a clinical practice treat-to-target (T2T) strategy in patients with …

Objective. Presence and levels of antibodies contribute to the classification of rheumatoid
arthritis. We investigated the longitudinal course of anti-citrullinated protein antibodies (ACPA) …

Background The last decades have for patients with inflammatory rheumatic diseases seen
a shift towards more physically active rehabilitation programs, often provided as out-patients …

Objective. To examine the 2-year disease course in patients with undifferentiated arthritis (UA)
focusing on fulfillment of the 2010 American College of Rheumatology/European League …

Objective To determine how the European League Against Rheumatism (EULAR) definition
of erosive disease (erosion criterion) contributes to the number of patients classified as …

Objectives To study occurrence of and factors associated with self-limiting arthritis among
patients fulfilling the 2010 ACR/EULAR classification criteria for rheumatoid arthritis (RA) (…

Objectives: To evaluate the effectiveness and safety of transdermal fentanyl (TDF) for the
treatment of pain associated with rheumatoid arthritis (RA) or osteoarthritis of the knee or hip (…

Objectives To describe the diagnostic spectrum, arthritis persistency and clinical outcomes
after 2 years in patients with inflammatory arthritis (IA) of less than 16 weeks’ duration. …